Signal 1

Signal 1 is a health AI start-up based in Toronto, Ontario, founded in April 2022. The company focuses on enhancing patient care through the responsible use of artificial intelligence. With a team of fewer than 25 employees, Signal 1 has successfully raised $10 million in seed-stage venture capital funding. The company was co-founded by Tomi Poutanen, a former Chief AI Officer at TD Bank, and has strong ties to the AI research community, including support from Nobel Laureate Dr. Geoffrey Hinton.

Signal 1 offers two main products: the Real-Time Patient Risk Prediction Platform and the Signal Health AI Platform. The Real-Time Patient Risk Prediction Platform provides healthcare professionals with immediate patient insights, integrating seamlessly into clinical workflows. The Signal Health AI Platform helps healthcare organizations manage AI effectively, featuring capabilities for validating AI models, monitoring performance, and optimizing investments. Signal 1 collaborates with major hospitals, including St. Michael's Hospital, to implement its solutions and improve healthcare delivery.